| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |